Latest California Healthline Stories
‘American Diagnosis’: Two Indigenous Students Share Their Path to Medicine
A lack of Native physicians means many tribal communities rely on doctors who don’t share their lived experience, culture, or spiritual beliefs. In Episode 9, meet two medical students working to join the ranks of Indigenous physicians.
‘True Cost of Aging’ Index Shows Many Seniors Can’t Afford Basic Necessities
The Elder Index, developed by researchers at the University of Massachusetts-Boston, shows that nearly 5 million older women living alone, 2 million older men living alone, and more than 2 million older couples have incomes that make them economically insecure.
Even Well-Intended Laws Can’t Protect Us From Inaccurate Provider Directories
State and federal laws require health plans to offer accurate lists of participating doctors and facilities, but consumers still struggle to get timely appointments with providers.
Ad Targeting Manchin and AARP Mischaracterizes Medicare Drug-Price Negotiations
The advocacy group American Commitment said empowering Medicare to negotiate drug prices would raid it of billions of dollars. Drug pricing experts say that that’s not the case and that such policies would instead reduce costs for the Medicare program and seniors.
Journalists Reexamine Mental Health Barriers, Gun Control Laws, and Homelessness
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Three Things About the Abortion Debate That Many People Get Wrong
The commonly repeated myths include arguments that only women who are pregnant are affected by the decision overturning Roe v. Wade, that Democratic lawmakers could have codified abortion protections before, and that Congress can easily get rid of federal laws restricting abortion.
Tres cosas sobre el debate del aborto que se entienden mal
Uno de los mitos: que la decisión de la Corte Suprema afecta solo a las mujeres que quieren realizarse el procedimiento, cuando en realidad afecta a toda la salud reproductiva.
KHN’s ‘What the Health?’: Drug Price Bill Is a Go in the Senate
Two things happened in Washington this week that were inevitable: President Joe Biden tested positive for covid-19, and the Senate agreed to move forward on a budget bill that includes only a sliver of what Biden hoped it would. Still, the bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line. Meanwhile, abortion battles continue to escalate around the country, with Texas leading the way in restrictions. Shefali Luthra of The 19th, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Jack Resneck Jr., the new president of the American Medical Association.
‘So Rudderless’: A Couple’s Quest for Autism Treatment for Their Son Hits Repeated Obstacles
Amparo and Victor Rios began searching for answers about their son’s development when he didn’t hit some milestones after turning 2. Three years later, they are still trying to get their insurance to pay for expensive therapy to help him.
Parents Become Drug Developers to Save Their Children’s Lives
Families affected by ultra-rare diseases are starting their own companies to speed the development of treatments for their kids, venturing into territory that traditional drugmakers deem too risky.